Publications

LSHTM

Found 0 results for your search. Showing 0 to 0.

No results could be found for your search.

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

The politics of Covid-19 vaccine confidence.

Sabahelzain, MM; Hartigan-Go, K; LARSON, HJ;

2021

Current opinion in immunology, (2021).71, 10.1016/j.coi.2021.06.007.

Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.

Mulot, M; Segalas, C; LEYRAT, C; Besançon, L;

2021

EUROPEAN JOURNAL OF EPIDEMIOLOGY, (2021).36 12 10.1007/s10654-021-00817-6.

Association between mobility, non-pharmaceutical interventions, and COVID-19 transmission in Ghana: a modelling study using mobile phone data.

GIBBS, H; LIU, Y; ABBOTT, S; Baffoe-Nyarko, I; Laryea, DO; Akyereko, E; Kuma-Aboagye, P; Asante, I; Mitjà, O; LSHTM CMMID COVID-19 working group,; Ampofo, W; Asiedu-Bekoe, F; MARKS, M; EGGO, RM;

2021

medRxiv (2021). 10.1101/2021.11.01.21265660.

Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review.

Saadi, N; Chi, Y-L; Ghosh, S; EGGO, RM; MCCARTHY, CV; QUAIFE, M; Dawa, J; JIT, M; VASSALL, A;

2021

BMC medicine, (2021).19 1 10.1186/s12916-021-02190-3.

Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.

Afrad, MH; Khan, MH; Rahman, SI A; Bin Manjur, OH; Hossain, M; Alam, AN; Khan, FI; Afreen, N; Haque, FT; Thomson, NR; Shirin, T; Qadri, F;

2021

Microbiology resource announcements, (2021).10 28 10.1128/mra.00560-21.

UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records.

Walker, JL; GRINT, DJ; STRONGMAN, H; EGGO, RM; Peppa, M; MINASSIAN, C; MANSFIELD, KE; RENTSCH, CT; DOUGLAS, IJ; MATHUR, R; WONG, AY S; Quint, JK; Andrews, N; Bernal, JL; SCOTT, JA; Ramsay, M; SMEETH, L; MCDONALD, HI;

2021

BMC public health, (2021).21 1 10.1186/s12889-021-10427-2.

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.

DAVIES, NG; JARVIS, CI; CMMID COVID-19 Working Group,; EDMUNDS, WJ; JEWELL, NP; DIAZ-ORDAZ, K; KEOGH, RH;

2021

Nature, (2021).593 7858 10.1038/s41586-021-03426-1.

Author Correction: A global survey of potential acceptance of a COVID-19 vaccine.

Lazarus, JV; Ratzan, SC; Palayew, A; Gostin, LO; LARSON, HJ; Rabin, K; Kimball, S; El-Mohandes, A;

2021

Nature medicine, (2021).27 2 10.1038/s41591-020-01226-0.

A comparison of 2020 health policy responses to the COVID-19 pandemic in Canada, Ireland, the United Kingdom and the United States of America.

Unruh, L; Allin, S; Marchildon, G; Burke, S; Barry, S; Siersbaek, R; Thomas, S; Rajan, S; Koval, A; Alexander, M; Merkur, S; Webb, E; Williams, GA;

2021

Health policy (Amsterdam, Netherlands), (2021).126 5 10.1016/j.healthpol.2021.06.012.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

Emary, KR W; Golubchik, T; Aley, PK; Ariani, CV; Angus, B; Bibi, S; Blane, B; Bonsall, D; Cicconi, P; Charlton, S; Clutterbuck, EA; Collins, AM; Cox, T; Darton, TC; Dold, C; Douglas, AD; Duncan, CJ A; Ewer, KJ; Flaxman, AL; Faust, SN; Ferreira, DM; Feng, S; Finn, A; Folegatti, PM; Fuskova, M; ... Oxford COVID-19 Vaccine Trial Group,

2021

Lancet (London, England), (2021).397 10282 10.1016/S0140-6736(21)00628-0.